loading...
 
INKTOMI.CO
"Stories That Matter"
 
Browse by Topics  
 
settings  
 
directory  
 
base  
Asia:
No. 97號, Songren Rd, Xinyi District,
Taipei City,
Taiwan 110
86 10 5385 6566
hello@inktomi.co

North America:
357 Bay St.,
Toronto, ON M5H 4A6
647 947 4255
hello@inktomi.co
 
 
 
 
 
 
Browse by Publishers  
 
 
 
 
 
#Shared
entrepreneurship
The Shift: Bikes, paddles and biotech
Spring is in the air and entrepreneurs are budding. Why it matters: As the local economy broadens beyond dependence on a few large companies, the...
axios.com - 30+ days ago
12.84k
12.01k
16.03k
+ Comment



You may also like:
nature
The hunt for the next CRISPR: how warring microbes are inspiring new technology
Gene editing and many other useful biotechnology tools came from studies of bacteria fighting off viral invaders. But scientists have only begun to...
nature.com - 30+ days ago
9.42k
9.75k
14.32k
+ Comment
writing
Generative AI Medical Writing Tool for the Pharmaceutical and Biotechnology Industries From TrialAssure Gets a Major Upgrade to Make Scientific Document Creation Easier | BioPharma Dive
CANTON, Mich. — TrialAssure®, a global leader in AI-enabled, human-driven solutions for the pharmaceutical industry and beyond, today announced a...
biopharmadive.com - 30+ days ago
8.84k
14.78k
7.72k
+ Comment
entrepreneurship
Deerfield secures more than $ 600M for its next biotech venture fund
Deerfield Management, a prolific backer of biotechnology companies, has raised more than $ 600 million to invest further in young companies working on...
biopharmadive.com - 30+ days ago
15.38k
14.87k
12.74k
+ Comment
nature
Journal targeted by paper mill still grappling with the aftermath years later
Dozens of problematic papers remain in the literature, after a publication hit by fraudsters pledged to tackle the issue. Miryam Naddaf A biotechnology...
nature.com - 30+ days ago
7.88k
8.41k
12.65k
+ Comment
business
8 Startup Opportunities In Anti-Ageing
The global anti-ageing market is rapidly expanding, driven by demographic shifts and new biotech breakthroughs. According to Grand View Research, the industry was valued at...
forbes.com - 30+ days ago
8.8k
12.89k
14.1k
+ Comment
auto
You're Not Escaping Auto Tariffs So Easily
Good morning! It's Thursday, April 10, 2025, and this is The Morning Shift: Your daily roundup of the top automotive headlines from around the world,...
jalopnik.com - 30+ days ago
14.65k
16.93k
11.88k
+ Comment
entrepreneurship
How automotive exec Crystal Brown founded CircNova, an AI drug discovery biotech
Tiny Michigan biotech startup CircNova has raised a $ 3.3 million seed round for its technology that uses AI to target “circular RNA.” The development holds promise...
techcrunch.com - 30+ days ago
9.63k
9.57k
10.59k
+ Comment
business
Which San Diego startup landed the top deal of 2024? Hint: it’s not a biotech
San Diego County startups recorded $ 5.7 billion in venture capital dollars in 2024, but the number of deals remains low. San Diego County startups...
sandiegouniontribune.com - 30+ days ago
14.29k
13.09k
15.94k
+ Comment
science
FUJIFILM Diosynth Biotechnologies and Regeneron Sign 10-year, $ 3+ Billion U.S. Manufacturing Deal
FUJIFILM Diosynth Biotechnologies signed a 10-year manufacturing supply agreement, valued at over $ 3 billion, with Regeneron Pharmaceuticals to...
genengnews.com - 30+ days ago
16.14k
7.97k
14.26k
+ Comment
how-to
Concerned after 23andMe bankruptcy? Here's a guide on how to download and delete your data
One of the most popularly-recognized biotechnology companies, 23andMe, has filed for bankruptcy. Before the company sells it assets, users are able to download and delete...
usatoday.com - 30+ days ago
18.1k
16.84k
12.74k
+ Comment
business
Amgen (AMGN) Reports Earnings Tomorrow: What To Expect
Biotech company Amgen (NASDAQ:AMGN) will be reporting earnings tomorrow afternoon. Here’s what to expect. Amgen beat analysts’ revenue expectations by...
yahoo.com - 30+ days ago
16.43k
9k
10.54k
+ Comment
business
BridgeBio Gets US Approval for Heart Drug to Compete with Pfizer
BridgeBio Pharma Inc. gained US approval for a drug to treat a progressive and deadly form of heart disease, paving the way for the biotech...
bloomberg.com - 30+ days ago
11.11k
13.9k
14.65k
+ Comment
science
Burst PIPEs? So-so returns for biotech's once-buzzy financing vehicle
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their...
statnews.com - 30+ days ago
10.42k
16.02k
9.64k
+ Comment
science
Araceli Biosciences raises $ 11.2M for imaging and AI analysis systems to help speed drug discovery
Portland- based biotech company Araceli Biosciences raised $ 11.2 million in new funding to fuel the expansion of its high-content imaging technology...
geekwire.com - 30+ days ago
9.18k
11.32k
16.07k
+ Comment
entrepreneurship
Chinese biotech firms cash in on promising drug discoveries via licensing deals
Licensing deals struck by Chinese biotech start-ups with overseas partners could potentially fetch billions in revenue if their drug candidates are...
scmp.com - 30+ days ago
13.63k
15.32k
13.28k
+ Comment
science
A kidney disease showdown, and eye risk linked to GLP-1s
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning,...
statnews.com - 30+ days ago
11.64k
13.4k
17.13k
+ Comment
technology
How to delete your 23andMe data after the company filed for bankruptcy
The genetic testing company 23andMe, best known for allowing people to trace their ancestry with an at-home kit, has been struggling financially for months. So...
npr.org - 30+ days ago
13.42k
13.11k
15.56k
+ Comment
entrepreneurship
Metsera prices IPO at $ 18 per share
• Clinical-stage biotechnology company Metsera (MTSR) priced its initial public offering of ~15.28M shares at a price to the public of $ 18.00 per...
seekingalpha.com - 30+ days ago
10.16k
10.64k
15.79k
+ Comment
health
Biogen CEO confirms he’s shopping for biotechs: ‘We will be doing deals’
SAN FRANCISCO — Biogen would like to make additional biotech acquisitions in 2025 beyond Friday’s offer to buy its financially troubled partner Sage...
statnews.com - 30+ days ago
15.03k
8.64k
7.78k
+ Comment
entrepreneurship
Innovating Patient Care for Rare Disorders: Putting Humanity First | YFS Magazine
Dr. Tejal Aslesh Tailor discusses advancements in AI, biotech innovations, regulatory compliance, and prioritizing patients with rare disorders. The...
yfsmagazine.com - 30+ days ago
13.3k
16.59k
9.48k
+ Comment
technology
Insiders Make Huge Purchases of These 4 Biotech Stocks
Insiders have been showing their love for these four biotech stocks, and one tech stock, lately with huge share purchases.The post Insiders Make Huge...
247wallst.com - 30+ days ago
7.44k
13.71k
16.64k
+ Comment
entrepreneurship
Retro Biosciences, backed by Sam Altman, is raising $ 1 billion to extend human lifespan
OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than...
techcrunch.com - 30+ days ago
15.96k
13.54k
17.35k
+ Comment
health
Company Seeking to Resurrect the Woolly Mammoth Creates a 'Woolly Mouse'
The biotech company Colossal Biosciences has long aspired to bring back the extinct woolly mammoth, which roamed the Northern Hemisphere thousands of...
scientificamerican.com - 30+ days ago
10.27k
14.81k
14.68k
+ Comment
health
The Converging Therapeutic Landscape of Oncology and Immunology: Accelerating Innovation in Biotech
This is not just about the science — it is about the leadership that enables it to reach the people who need it most. With the...
medcitynews.com - 30+ days ago
13.6k
9.05k
7.07k
+ Comment